Clyde Biosciences

Clyde Biosciences provides cardiomyocyte assays and develops safety assays for cardiac drug discovery. Their CellOPTIQ® platform generates functional data relevant to humans.

CiPA Assay
Custom R&D
Voltage Assay
Calcium Assay
Heart Failure Assay
Contractility Assay
In Silico Modelling
CellOPTIQ® Platform
Primary Screening Assay
Mechanistic CV Toxicity Assay

Size

Small

Phone

+44 (0)1698 539920

Website

clydebio.com

Available in Endole App

Locations

BioCity Scotland, Bo'Ness Rd, ML1 5UH

Digital Popularity

Popularity over time

Social Media

LinkedIn
2,370 Followers

Competitors

BioAscent

BioAscent is a leading provider of integrated drug discovery services based at the former Organon / MSD R&D site in Newhouse, Scotland, UK.

Company Details

Clyde Biosciences is operated by Clyde Biosciences Limited and is a Active company incorporated on 7 March 2012 with the registered office located in Motherwell, Lanarkshire. Clyde Biosciences Limited was registered 13 years ago.

Status

Active

Size

Micro

Directors

Age

13 years old

Employees

Turnover

Unreported

Total Assets

£278.99K